Avicanna Inc. (TSX: AVCN)
AVCN trades on the Toronto Stock Exchange in Life Sciences, headquartered in Ontario. Numbers below come from the TMX issuer list, Yahoo Finance closes and the Bank of Canada rate, each with its source.
Issuer list, sector and C$ market cap: TMX Group TSX and TSXV listed companies, as of October 31, 2026. US$ figures convert C$ at 1.4257 C$ per US$, the Bank of Canada daily rate for November 13, 2026. Close and returns: Yahoo Finance daily closes for AVCN.TO, last bar 2026-11-13, computed by MarginsX.
Profile
| Field | Value |
|---|---|
| Ticker | AVCN on the Toronto Stock Exchange |
| Yahoo symbol | AVCN.TO |
| Sector | Life Sciences, Cannabis |
| Headquarters | Ontario |
| Listed | 2019-07-18 |
| Listing type | Other |
| Shares outstanding | 137,717,185 |
| Also listed on | No interlisting on the TMX list |
| Index membership | Not in an S&P/TSX index per the TMX list |
| SEC CIK | No SEC filer matched on exact name with a Canadian address or US interlisting |
| Website | No company website on record |
Returns
| Window | Return |
|---|---|
| 1 day | +17.6% |
| 1 week | -4.8% |
| 1 month | -13.0% |
| 3 months | -23.1% |
| 6 months | -20.0% |
| Year to date | -55.6% |
| 1 year | -63.0% |
| From 52-week high | -61.5% |
| 52-week range | C$0.0850 to C$0.2600 |
Links
SEDAR+ is linked for searching only; nothing on this page is taken from it.
Recent Canadian filings by type
1 documents in 1 types. Each title links to the document at its source.
Other (1)
| Document | Type | Filed |
|---|---|---|
| ONTARIO SECURITIES COMMISSION APPROVES AVICANNA’S APPLICATION FOR MANAGEMENT CEASE TRADE ORDER | Other | No date |
Sources: Company investor-relations website (links only, documents not copied). Documents filed only on SEDAR+ are not copied here; search SEDAR+ for the full record.
Trading halts
No CIRO halt notices for this company in our data.
Source: Canadian Investment Regulatory Organization (CIRO), Halts/Resumptions newsroom, notices since 2024-10-15.
Upcoming events
No upcoming earnings date, call or meeting announced in the SEC filings and newswire releases we read.
Source: dates read from the company's SEC filings and newswire releases; each row links to the announcement.
US private placements (SEC Form D)
| Filed | Securities | Sold | Offered | Filing |
|---|---|---|---|---|
| 2022-10-24 | Equity | US$2.0M | US$2.0M | SEC EDGAR |
| 2022-06-27 | Equity | US$1.1M | US$2.1M | SEC EDGAR |
| 2022-06-23 | Equity | US$79K | US$2.1M | SEC EDGAR |
| 2021-03-19 | Equity, Option To Acquire | US$4.5M | US$4.5M | SEC EDGAR |
| 2020-09-03 | Equity | US$2.1M | US$8.0M | SEC EDGAR |
Source: SEC EDGAR Form D filings matched on exact issuer name. Amounts are US$ as filed.
Peers in Life Sciences
| Ticker | Company | Exchange | Market cap (C$) | 1 month | 1 year |
|---|---|---|---|---|---|
| VVTM | VVT Med Inc. | TSXV | C$15.0M | -20.0% | -46.7% |
| FREQ | Frequency Exchange Corp. | TSXV | C$15.5M | 0.0% | -13.3% |
| VPT | VentriPoint Diagnostics Ltd. | TSXV | C$15.6M | -22.2% | -30.0% |
| HEM | Hemostemix Inc. | TSXV | C$13.1M | -16.7% | -41.2% |
| MDX | MedX Health Corp. | TSXV | C$13.1M | -20.0% | -33.3% |
The app has the price chart, every filing, private raises and the full peer set for AVCN.
Open in the app